Noah Gaarder-Feingold represents public and private companies across a range of corporate matters, including public offerings, private financings, M&A and general corporate governance.

Download full bio 


  • Ambrx Biopharma – $126 Million IPO 

  • Reneo Pharmaceuticals – $94 Million IPO 


  • University of San Diego, School of Law
    JD, summa cum laude, Order of the Coif, 2020

  • University of California, Los Angeles
    BA, Film
    cum laude, 2013

Admissions & Credentials